BIOMAT Database Logo BIOMAT Database Logo

Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytes. 1988

G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan, Italy.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous
D017710 Lymphocyte Transfusion The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor. Lymphocyte Transfusions,Transfusion, Lymphocyte,Transfusions, Lymphocyte

Related Publications

G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.
August 1994, Journal of the National Cancer Institute,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Re: Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.
February 1995, Journal of the National Cancer Institute,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4.
November 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.
September 1991, Japanese journal of cancer research : Gann,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.
August 2012, Journal of translational medicine,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma.
April 1996, European journal of cancer (Oxford, England : 1990),
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.
July 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
[Tumor-infiltrating lymphocytes from human metastatic melanoma].
June 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Metabolism of peripheral lymphocytes, interleukin-2-activated lymphocytes and tumor-infiltrating lymphocytes from 31P NMR studies.
November 1989, FEBS letters,
G Parmiani, and G Fossati, and M Radrizzani, and C Gambacorti-Passerini, and R Marolda, and N Cascinelli
Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspective.
May 2012, Experimental and therapeutic medicine,
Copied contents to your clipboard!